Twitxy Saved

GU Cancer Research Program @HuntsmanCancer

Verified account This account is verified. Learn more

@Huntsman_GU

Patient-focused care and research, clinical trials in #Genitourinary cancers #GU #Prostate #Kidney #Bladder #GermCell. @HuntsmanCancer @UUtah
Joined November 2020
244 Following 786 Followers 898 Posts

Latest posts 5

GU Cancer Research Program @HuntsmanCancer Verified account @Huntsman_GU
Congrats George @ggebraelmd for your work on this patient level analysis of a @SWOG ph3 trial (n=1313 pts) 👉data warrant inclusion of baseline bone pain in prognostic models in mHSPC #ProstateCancer Cc: @UofUInternalMed @carolinemilneMD @InadomiJ @huntsmancancer @neerajaiims
Just in @JAMANetworkOpen 👉 Baseline bone pain associated with ⬇️ survival in mHSPC #prostatecancer (pt level analysis of a @SWOG ph3 trial) 👇 mHSPC pts w/ bone pain may be prioritized for trials 👉 tinyurl.com/5xa82bt6 @neerajaiims @Huntsman_GU @OncoAlert @urotoday
View quoted post on X
GU Cancer Research Program @HuntsmanCancer Verified account @Huntsman_GU
Congrats @neerajaiims & team for publishing this high-impact, practice-influencing research in @NatureMedicine Open access article👉 tinyurl.com/wntrx75a cc' @urotoday @Uromigos @PCFnews @APCCC_Lugano @NeliMUlrich @MikeGoodMD @InadomiJ @huntsmancancer @UofUInternalMed @UUtah
Neeraj Agarwal, MD, FASCO Verified account @neerajaiims Dec 4, 2023
Just in @NatureMedicine👉Results from Ph3 TALAPRO-2 trial in 399 pts w/ HRR-deficient mCRPC #prostatecancer👉enza + tala vs. enza, rPFS HR 0.44, OS trending strongly HR 0.69, efficacy in multiple HRR gene subsets⬇️open access👉tinyurl.com/wntrx75a @OncoAlert @PCF_Science
View quoted post on X
0 replies 7 reposts 23 likes 3.1K views View on X
GU Cancer Research Program @HuntsmanCancer Verified account @Huntsman_GU
Congrats to our faculty Dr. Agarwal @neerajaiims for the first author publication in @TheLancet 👇of the results of his phase 3 trial in mCRPC #prostatecancer Open access full text weblink👉 thelancet.com/journals/lance… @huntsmancancer @Huntsman_CTO @helops79 @GarridoLagunaMD @theresalwerner @MoehleJessica @jujubatten @JenLloyd42 @MaxTheSFCat @AlanaWelm @Sonampuri @SiwenONC @InadomiJ
Neeraj Agarwal, MD, FASCO Verified account @neerajaiims Jun 4, 2023
We report in @TheLancet : Primary efficacy data from TALAPRO-2 Phase 3 trial in mCRPC #prostatecancer : Talazoparib + Enza improves outcomes in all subgroups vs Enza. Prospective tissue testing in 100% pts, randomization stratified by HRR status @oncoalert @urotoday @PCF_Science
View quoted post on X